SCM
ANIP icon

Sio Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Sio Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05M Sell
97,305
-168,238
-63% -$13.5M 1.33% 28
2026
Q1 		$20.4M Buy
265,543
+178,271
+204% +$13.9M 2.93% 12
2025
Q4 		$6.89M Buy
87,272
+31,549
+57% +$2.73M 1.08% 25
2025
Q3 		$5.1M Sell
55,723
-57,200
-51% -$4.66M 1.29% 22
2025
Q2 		$7.37M Buy
112,923
+25,625
+29% +$1.67M 2.81% 13
2025
Q1 		$5.84M Sell
87,298
-72,753
-45% -$4.35M 1.74% 16
2024
Q4 		$8.85M Buy
+160,051
New +$9.19M 2.49% 14
2024
Q3 		– Sell
-71,740
Closed -$4.57M – 41
2024
Q2 		$4.57M Sell
71,740
-15,614
-18% -$1.01M 1.24% 19
2024
Q1 		$6.04M Buy
+87,354
New +$5.27M 1.8% 17
2022
Q4 		– Sell
-40,000
Closed -$1.29M – 48
2022
Q3 		$1.29M Hold
40,000
– – 0.41% 33
2022
Q2 		$1.19M Hold
40,000
– – 0.45% 39
2022
Q1 		$1.12M Hold
40,000
– – 0.37% 47
2021
Q4 		$1.84M Buy
+40,000
New +$1.72M 0.56% 45

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's ANIP Position: Q2 2026 in Review

Sio Capital Management reduced its ANI Pharmaceuticals (ANIP) stake by 63% in Q2 2026, selling an estimated $13.5M and leaving 97,305 shares worth $8.05M. The position accounts for 1.33% of the portfolio, ranked #28.

Sio Capital Management first reported a position in ANIP in Q4 2021 and has held it in 13 quarters since. The position peaked at $20.4M in Q1 2026. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Sio Capital Management held 97,305 shares of ANI Pharmaceuticals worth $8.05M as of Q2 2026.
  • Sio Capital Management sold 168,238 ANI Pharmaceuticals shares in Q2 2026, an estimated $13.5M.
  • ANI Pharmaceuticals made up 1.33% of Sio Capital Management's portfolio in Q2 2026, its #28 holding.
  • Sio Capital Management first reported a position in ANI Pharmaceuticals in Q4 2021 and has held it in 13 quarters since.
  • Sio Capital Management's ANI Pharmaceuticals position peaked at $20.4M in Q1 2026.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.